UVM Cancer Center rolling out innovative new blood cancer treatment
Vermont Public
An innovative cancer treatment that uses a patient’s own immune system to attack the disease is now available for patients in Vermont and northern New York for the first time.
CAR T-cell therapy was approved in 2017 for a variety of blood cancers, and has led to encouraging results for patients.
Dr. James Gerson was among the first physicians in the country to use the treatment in a clinical setting, at the University of Pennsylvania.
He’s now at the University of Vermont Cancer Center, which just began its own CAR T-cell therapy program. And he joined Vermont Public’s Mary Williams Engisch to talk about the treatment. Their conversation below has been edited and condensed for clarity.